Table 5.

the distribution of 21-day outcomes among the N=488 non-IND patients by estimated latent subgroup index, where the p-value between the 21-day outcome and the latent subgroup index is <.001.

characteristics	All N=488	Subgroup1 N=136	Subgroup2 N=95	Subgroup3 N=61	Subgroup4 N=135	Subgroup5 N=61
21-day Outcome*	N=488	N=136	N=95	N=61	N=135	N=61
Death by day 7	30(6%)	2(1%)	1(1%)	4(7%)	12(9%)	11(18%)
LTx by day 7	56(11%)	1(1%)	5(5%)	9(15%)	18(13%)	23(38%)
Death between day 8–21	29(6%)	0(0%)	3(3%)	2(3%)	16(12%)	8(13%)
LTx between day 8–21	20(4%)	0(0%)	1(1%)	0(0%)	16(12%)	3(5%)
Alive with native liver at day 21	353(72%)	133(98%)	85(89%)	46(75%)	73(54%)	16(26%)
Total death by day 21	59(12%)	2(1%)	4(4%)	6(10%)	28(21%)	19(31%)
Total LTx by day 21	76(16%)	1(1%)	6(6%)	9(15%)	34(25%)	26(43%)